Search
for
Sort by
Research 301–330 of 1000+
- Androgenic alopecia--Its characteristics and perspectives
- Tratamento de queimaduras de carboxiterapia em modelo experimental
- Body composition and physical fitness in transgender versus cisgender individuals: a systematic review with meta-analysis
- Hair cycle and dermic follicular volume of the wild rodent, agouti (Dasyprocta prymnolopha), raised in captivity, in the northeast region of Brazil
- The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Finasteride for the Treatment of Hidradenitis Suppurativa in Children and Adolescents
- Response of Sows and Litters to Added Dietary Biotin in Environmentally Regulated Facilities
- Biochemical examination of fetal skin biopsy specimens obtained by fetoscopy: Use of the method for analysis of keratins and filaggrin
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- 54022 Pooled Safety Assessments from the Multinational Phase 3 THRIVE-AA1 and THRIVE-AA2 Trials of Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata
- 41701 Efficacy of the Oral JAK1/JAK2 Inhibitor CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata: Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 Phase 3 Trial
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion
- 62339 Improvement in anxiety and depression in adult patients with severe alopecia areata treated with deuruxolitinib: Pooled data from the THRIVE-AA1 and THRIVE-AA2 Phase 3 trials
- 60058 Change in patient-reported hair satisfaction during deuruxolitinib treatment of severe alopecia areata: Pooled data from the Phase 3 THRIVE-AA1 and THRIVE-AA2 trials
- 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Issue Information
- Trichohyalin: Purification from Porcine Tongue Epithelium and Characterization of the Native Protein
- A Study of the Frequency of Contamination of Products Applied to the Skin
- Mrp3, a Mitogen-Regulated Protein/Proliferin Gene Expressed in Wound Healing and in Hair Follicles*
- <i>Mrp4</i>, A New Mitogen-Regulated Protein/Proliferin Gene; Unique in this Gene Family for its Expression in the Adult Mouse Tail and Ear<sup>1</sup>
- Successful Hair Re-growth with Multimodal Treatment of Early Cicatricial Alopecia in Discoid Lupus Erythematosus
- High-resolution stable isotope profiles of modern elephant (Loxodonta africana) tusk dentin and tail hair from Kenya: Implications for identifying seasonal variability in climate, ecology, and diet in ancient proboscideans
- Regeneration of fat cells from myofibroblasts during wound healing
- WNT10A promotes an invasive and self-renewing phenotype in esophageal squamous cell carcinoma
- Trichohyalin: Presence in the Granular Layer and Stratum Corneum of Normal Human Epidermis
- Current Status of Fractional Laser Resurfacing
- Mouse Intestinal Krt15+ Crypt Cells Are Radio-Resistant and Tumor Initiating